The MD Magazine Ankylosing Spondylitis condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.
Novartis Launches Head-to-head Clinical Trial for Secukinumab and Biosimilar
Psoriatic Disease Linked to Higher Risk of Pathological Fractures
Researchers in Portugal Examine Role of Interleukin-17 in Uveitis
Combination of TNFis and NSAIDs May Slow Ankylosing Spondylitis
Anti-TNF Treatments for Ankylosing Spondylitis Decrease Need for Hip Replacement
Long-Term Secukinumab Treatment Safe and Effective for Patients with Psoriatic Arthritis
Adalimumab: Efficacy and Adverse Effects for Patients with Active Noninfectious Uveitis
Golimumab Effective Against Uveitis Associated with Ankylosing Spondylitis
Study Shows TNF Inhibitors Prevent Relapse of Uveitis in Most Patients with Ankylosing Spondylitis
Biosimilar Drugs for Psoriatic Arthritis, Other Conditions, One Step Closer to Approval
Next Page >>
Ingrezza Improves TD Symptoms In Year-long Extension
Sources of Information for Self-care Among Patients Living with HIV
Running Away or Righting The Way: Is Psilocybin a Viable Psychiatric Treatment?
Top 10 Painkillers in the US
Working Memory, Vigilance Linked to ADHD
Affordable Care Act
PHYSICIAN'S MONEY DIGEST >
MD Magazine Resources
Terms & Conditions
Copyright© MD Magazine 2006-2017 Intellisphere, LLC. All Rights Reserved.